BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

437 related articles for article (PubMed ID: 11340253)

  • 41. CD7+ and CD56+ myeloid/natural killer cell precursor acute leukemia treated with idarubicin and cytosine arabinoside.
    Handa H; Motohashi S; Isozumi K; Komatsumoto S; Nara M
    Acta Haematol; 2002; 108(1):47-52. PubMed ID: 12145468
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Acute monoblastic leukemia with tetrasomy 8].
    Kameoka J; Horiuchi T; Miyamura K; Miura I; Okuda M; Nomura J; Hirokawa M; Sawada K; Sasaki T
    Rinsho Ketsueki; 2006 Aug; 47(8):770-6. PubMed ID: 16986717
    [TBL] [Abstract][Full Text] [Related]  

  • 43. PML/RAR alpha transcripts monitored by polymerase chain reaction in acute promyelocytic leukemia during complete remission, relapse and after bone marrow transplantation.
    Perego RA; Marenco P; Bianchi C; Cairoli R; Urbano M; Nosari AM; Muti G; Morra E; Del Monte U
    Leukemia; 1996 Feb; 10(2):207-12. PubMed ID: 8637228
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Acute myeloid leukemia possibly producing thrombopoietic factor(s).
    Fujita A; Matsuoka M; Shimonaka Y; Imai N; Asano S
    Jpn J Clin Oncol; 1993 Dec; 23(6):366-72. PubMed ID: 7506802
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Cytogenetics for detection of minimal residual disease in acute myeloblastic leukemia.
    Freireich EJ; Cork A; Stass SA; McCredie KB; Keating MJ; Estey EH; Kantarjian HM; Trujillo JM
    Leukemia; 1992 Jun; 6(6):500-6. PubMed ID: 1602788
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Quantitative nested reverse transcriptase PCR vs. real-time PCR for measuring AML1/ETO (MTG8) transcripts.
    Takenokuchi M; Yasuda C; Takeuchi K; Nakamachi Y; Mukai M; Kondo S; Kumagai S; Saigo K; Murayama T; Koizumi T; Tatsumi E
    Clin Lab Haematol; 2004 Apr; 26(2):107-14. PubMed ID: 15053804
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Cytoreduction with iodine-131-anti-CD33 antibodies before bone marrow transplantation for advanced myeloid leukemias.
    Burke JM; Caron PC; Papadopoulos EB; Divgi CR; Sgouros G; Panageas KS; Finn RD; Larson SM; O'Reilly RJ; Scheinberg DA; Jurcic JG
    Bone Marrow Transplant; 2003 Sep; 32(6):549-56. PubMed ID: 12953125
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Molecular characteristic of acute leukemias with t(16;21)/FUS-ERG.
    Zerkalenkova E; Panfyorova A; Kazakova A; Baryshev P; Shelihova L; Kalinina I; Novichkova G; Maschan M; Maschan A; Olshanskaya Y
    Ann Hematol; 2018 Jun; 97(6):977-988. PubMed ID: 29427188
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Two childhood cases of acute leukemia with t(16;21)(p11.2;q22): second case report of infantile acute lymphoblastic leukemia with unusual type of FUS-ERG chimeric transcript.
    Oh SH; Park TS; Choi JR; Lee S; Cho SY; Kim SY; Kim J; Park JK; Song SA; Lee JY; Shin JH; Kim HR; Lee JN
    Cancer Genet Cytogenet; 2010 Jul; 200(2):180-3. PubMed ID: 20620604
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Myeloid/NK cell precursor acute leukemia lost both CD13 and CD33 at first diagnosis.
    Ogura K; Kimura F; Kobayashi S; Torikai H; Ikeda T; Sato K; Motoyoshi K
    Leuk Res; 2006 Jun; 30(6):761-3. PubMed ID: 16140376
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Acute promyelocytic leukemia relapsing as secondary acute myelogenous leukemia with translocation t(3;21)(q26;q22) and RUNX1-MDS1-EVI1 fusion transcript.
    Park TS; Choi JR; Yoon SH; Song J; Kim J; Kim SJ; Kwon O; Min YH
    Cancer Genet Cytogenet; 2008 Dec; 187(2):61-73. PubMed ID: 19027486
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Establishment of a novel human acute myeloblastic leukemia cell line (YNH-1) with t(16;21), t(1;16) and 12q13 translocations.
    Yamamoto K; Hamaguchi H; Nagata K; Kobayashi M; Tanimoto F; Taniwaki M
    Leukemia; 1997 Apr; 11(4):599-608. PubMed ID: 9096702
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Bone marrow transplantation for advanced acute leukemia: a pilot study of high-energy total body irradiation, cyclophosphamide and continuous infusion etoposide.
    Bostrom B; Weisdorf DJ; Kim T; Kersey JH; Ramsay NK
    Bone Marrow Transplant; 1990 Feb; 5(2):83-9. PubMed ID: 2107007
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Establishment and characterization of a novel acute myeloid leukemia cell line, JIH-4, carrying a t(16;21)(p11.2;q22) and expressing the FUS-ERG fusion.
    Jiang H; Qiu H; Xue Y; Pan J; Wu Y; Zhang J; Zheng J; Wang Q; Liang J; Chen S
    Cancer Genet; 2011 Apr; 204(4):219-23. PubMed ID: 21536242
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Unrelated donor bone marrow transplantation for acute mixed lineage (myeloid and B-lymphoid lineage) leukemia in an adult with Down syndrome.
    Takagi K; Yoshida A; Kinoshita K; Iwashima D; Imamaura S; Iwasaki H; Tsutani H; Ueda T
    Ann Hematol; 2003 Apr; 82(4):236-40. PubMed ID: 12707727
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Detection of residual disease in AML patients by use of double immunological marker analysis for terminal deoxynucleotidyl transferase and myeloid markers.
    Adriaansen HJ; Jacobs BC; Kappers-Klunne MC; Hählen K; Hooijkaas H; van Dongen JJ
    Leukemia; 1993 Mar; 7(3):472-81. PubMed ID: 7680403
    [TBL] [Abstract][Full Text] [Related]  

  • 57. A phase I trial of humanized monoclonal antibody HuM195 (anti-CD33) with low-dose interleukin 2 in acute myelogenous leukemia.
    Kossman SE; Scheinberg DA; Jurcic JG; Jimenez J; Caron PC
    Clin Cancer Res; 1999 Oct; 5(10):2748-55. PubMed ID: 10537338
    [TBL] [Abstract][Full Text] [Related]  

  • 58. B-Lymphoid and myeloid lineages biphenotypic acute leukemia with t(8;21)(q22;q22).
    He G; Wu D; Sun A; Xue Y; Jin Z; Qiu H; Tang X; Miao M; Fu Z; Ma X; Wang X; Chen Z; Ruan C
    Int J Hematol; 2008 Mar; 87(2):132-136. PubMed ID: 18288568
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Phenotypical characteristics of acute myelocytic leukemia associated with the t(8;21)(q22;q22) chromosomal abnormality: frequent expression of immature B-cell antigen CD19 together with stem cell antigen CD34.
    Kita K; Nakase K; Miwa H; Masuya M; Nishii K; Morita N; Takakura N; Otsuji A; Shirakawa S; Ueda T
    Blood; 1992 Jul; 80(2):470-7. PubMed ID: 1378322
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Challenge in diagnosis of CD56+ lymphoproliferative disorders: two cases of CD56+CD33+ lymphoma/leukemia.
    Yang X; Wasserman PG; Bhargava A; Iqbal U; Ragnauth S; Fuchs A
    Arch Pathol Lab Med; 2004 Aug; 128(8):e100-3. PubMed ID: 15270596
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.